(Q51436028)

English

Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine.

scientific article published in October 1999

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/10528123

Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine. (English)

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/10528123

3

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/10528123

author name string

Duncan GE

1

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/10528123

Miyamoto S

2

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/10528123

Lieberman JA

4

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/10528123

language of work or name

0 references

publication date

1 October 1999

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/10528123

number of pages

13

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/10528123

843

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/10528123

1-2

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/10528123

171-183

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/10528123

Corticolimbic dopamine neurotransmission is temporally dissociated from the cognitive and locomotor effects of phencyclidine.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Effects of ketamine on thought disorder, working memory, and semantic memory in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Observations on the psychotomimetic effects of Sernyl.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

COMPARISON OF AMPHETAMINE PSYCHOSIS AND SCHIZOPHRENIA.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Behavioural and neurochemical interactions of the AMPA antagonist GYKI 52466 and the non-competitive NMDA antagonist dizocilpine in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Inhibition of mammalian brain acetylcholinesterase by ketamine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

The taming of ketamine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

The glutamatergic dysfunction hypothesis for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Dopamine in schizophrenia: a review and reconceptualization

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

PHARMACOLOGIC EFFECTS OF CI-581, A NEW DISSOCIATIVE ANESTHETIC, IN MAN.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Topographic patterns of brain activity in response to swim stress: assessment by 2-deoxyglucose uptake and expression of Fos-like immunoreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Differential effects of clozapine and haloperidol on ketamine-induced brain metabolic activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Brain activity patterns: assessment by high resolution autoradiographic imaging of radiolabeled 2-deoxyglucose and glucose uptake

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Effects of phencyclidine on ventral tegmental A10 dopamine neurons in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Non-competitive N-methyl-D-aspartate antagonists are potent activators of ventral tegmental A10 dopamine neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Effects of competitive N-methyl-d-aspartate antagonists on midbrain dopamine neurons: An electrophysiological and behavioral comparison to phencyclidine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

NMDA-dependent modulation of CA1 local circuit inhibition.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Altered metabolic activity in the cerebral cortex of rats exposed to ketamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

The non-NMDA glutamate receptor antagonist GYKI 52466 counteracts locomotor stimulation and anticataleptic activity induced by the NMDA antagonist dizocilpine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Effect of phencyclidine on dopamine release in the rat prefrontal cortex; an in vivo microdialysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

In vivo regulation of extracellular dopamine in the neostriatum: influence of impulse activity and local excitatory amino acids

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Provocative tests with psychostimulant drugs in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Clozapine blunts N-methyl-D-aspartate antagonist-induced psychosis: a study with ketamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

On the roles of dopamine D-1 vs. D-2 receptors for the hyperactivity response elicited by MK-801

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

The dopamine hypothesis of schizophrenia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Effects of dizocilpine (MK-801) on rat midbrain dopamine cell activity: differential actions on firing pattern related to anatomical localization

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Glutamate receptor dysfunction and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Comparative effects of acute and chronic administration of amphetamine on local cerebral glucose utilization in the conscious rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Effects of dopamine D1 and D2 receptor blockade on MK-801-induced hyperlocomotion in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Correlation of dose-dependent effects of acute amphetamine administration on behavior and local cerebral metabolism in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Differential effects of phencyclidine (PCP) and ketamine on mesocortical and mesostriatal dopamine release in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

DNQX inhibits phencyclidine (PCP) and ketamine induction of the hsp70 heat shock gene in the rat cingulate and retrosplenial cortex

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Properties of the optical isomers and metabolites of ketamine on the high affinity transport and catabolism of monoamines

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

The interaction of ketamine with the opiate receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Drugs, neurotransmitters, and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Electrophysiological effects of selective sigma-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG).

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

M100907 and clozapine, but not haloperidol or raclopride, prevent phencyclidine-induced blockade of NMDA responses in pyramidal neurons of the rat medial prefrontal cortical slice.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Effects of d- and l-amphetamine on local cerebral glucose utilization in the conscious rat

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

MK-801 elevates the extracellular concentration of dopamine in the rat prefrontal cortex and increases the density of striatal dopamine D1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

The role of dopamine and AMPA/kainate receptors in the nucleus accumbens in the hypermotility response to MK801

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2899%2901776-X

7 January 2021

Identifiers

10.1016/S0006-8993(99)01776-X

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/10528123

1 reference

Europe PubMed Central

5 April 2018

http://europepmc.org/abstract/MED/10528123

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51436028&oldid=1772295050"